Analysen zu OMX Nordic 40-Werten
17.04.25 | ABB Underperform | Bernstein Research | |
17.04.25 | A.P. Moeller - Maersk A-S Underperform | Bernstein Research | |
17.04.25 | ABB Neutral | UBS AG | |
17.04.25 | ABB Hold | Jefferies & Company Inc. | |
17.04.25 | Volvo AB Buy | Goldman Sachs Group Inc. | |
17.04.25 | ABB Sector Perform | RBC Capital Markets | |
16.04.25 | Ericsson Sell | Goldman Sachs Group Inc. | |
16.04.25 | Ericsson Neutral | JP Morgan Chase & Co. | |
16.04.25 | Novo Nordisk Overweight | Barclays Capital | |
15.04.25 | Ericsson Sell | UBS AG | |
15.04.25 | ABB Sector Perform | RBC Capital Markets | |
15.04.25 | Volvo AB Outperform | RBC Capital Markets | |
10.04.25 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
10.04.25 | ABB Sell | Deutsche Bank AG | |
10.04.25 | AstraZeneca Buy | UBS AG | |
09.04.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
09.04.25 | AstraZeneca Outperform | Bernstein Research | |
08.04.25 | Volvo AB Buy | Jefferies & Company Inc. | |
08.04.25 | Nokia Buy | Deutsche Bank AG | |
08.04.25 | Nokia Market-Perform | Bernstein Research | |
08.04.25 | Ericsson Underperform | Bernstein Research | |
08.04.25 | Novo Nordisk Buy | UBS AG | |
07.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
07.04.25 | AstraZeneca Hold | Deutsche Bank AG | |
07.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
07.04.25 | Novo Nordisk Buy | UBS AG | |
04.04.25 | Novo Nordisk Buy | UBS AG | |
04.04.25 | ABB Sector Perform | RBC Capital Markets | |
04.04.25 | A.P. Moeller - Maersk A-S Underweight | JP Morgan Chase & Co. | |
03.04.25 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
03.04.25 | AstraZeneca Outperform | Bernstein Research | |
03.04.25 | Novo Nordisk Market-Perform | Bernstein Research | |
03.04.25 | Volvo AB Underperform | Bernstein Research | |
03.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
03.04.25 | Nokia Overweight | JP Morgan Chase & Co. | |
03.04.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
01.04.25 | AstraZeneca Buy | UBS AG | |
01.04.25 | Nokia Overweight | JP Morgan Chase & Co. | |
01.04.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
01.04.25 | Volvo AB Underperform | Bernstein Research |